Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma

Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma
Author :
Publisher :
Total Pages : 228
Release :
ISBN-10 : OCLC:914487250
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma by : Catherine Belle Meador

Download or read book Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma written by Catherine Belle Meador and published by . This book was released on 2015 with total page 228 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma Related Books

Optimizing the Sequence of Targeted Therapy in EGFR-mutant Lung Adenocarcinoma
Language: en
Pages: 228
Authors: Catherine Belle Meador
Categories: Electronic dissertations
Type: BOOK - Published: 2015 - Publisher:

DOWNLOAD EBOOK

Molecular Targeted Therapy of Lung Cancer
Language: en
Pages: 321
Authors: Yuichi Takiguchi
Categories: Medical
Type: BOOK - Published: 2017-01-24 - Publisher: Springer

DOWNLOAD EBOOK

This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dram
Acquired Resistance to Targeted Therapy in EGFR-mutant Lung Adenocarcinoma
Language: en
Pages: 145
Authors: Caroline Amalia Nebhan
Categories: Electronic dissertations
Type: BOOK - Published: 2014 - Publisher:

DOWNLOAD EBOOK

Guide to Targeted Therapies: EGFR mutations in NSCLC
Language: en
Pages: 75
Authors: Federico Cappuzzo
Categories: Medical
Type: BOOK - Published: 2014-09-25 - Publisher: Springer

DOWNLOAD EBOOK

Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current
EGFR-Directed Therapy in Lung Cancer
Language: en
Pages: 72
Authors: So Yeon Kim
Categories: Medical
Type: BOOK - Published: 2023-01-26 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a clinically important driver alteration affecting approximately one-third